NCT01904123: STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain |
|
|
| Completed | 1 | 8 | US | Laboratory Biomarker Analysis, Pharmacological Study, STAT3 Inhibitor WP1066, WP1066 | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Recurrent Brain Neoplasm, Recurrent Glioblastoma, Recurrent Malignant Glioma | 03/22 | 03/22 | | |
NCT04334863: WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors |
|
|
| Completed | 1 | 10 | US | WP1066, STAT3 Inhibitor WP1066 | Emory University, CURE Childhood Cancer, Inc., Peach Bowl LegACy Fund | Brain Tumor, Medulloblastoma, Brain Metastases | 02/23 | 02/23 | | |